MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-30-2026
OptiNose EBITDA per Share 2011-2026 | OPTN
Annual EBITDA per Share OptiNose
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.58 | -2.99 | -0.64 | -1.16 | -1.78 | -2.26 | -2.5 | -4.38 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.64 | -4.38 | -2.16 |
Quarterly EBITDA per Share OptiNose
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.65 | - | -0.01 | -0.04 | -1.06 | - | -0.01 | -0.04 | -0.13 | - | -0.13 | -0.18 | -0.26 | - | -0.24 | -0.36 | -0.42 | - | -0.34 | -0.48 | -0.57 | - | -0.46 | -0.61 | -0.65 | - | -0.56 | -0.59 | -0.76 | -0.52 | -3.22 | -2.03 | -1.79 | -1.2 | -1.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -3.22 | -0.667 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-2.73 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
0.19 | $ 5.64 | -3.42 % | $ 83.8 M | USA |
 |
HEXO Corp.
HEXO
|
-2.75 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-6.95 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-0.61 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-0.01 | $ 2.8 | - | $ 1.07 B | Canada |
 |
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
0.87 | $ 33.79 | -2.59 % | $ 1.24 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.47 | $ 2.46 | -0.81 % | $ 312 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.01 | -2.4 % | $ 109 M | Canada |
 |
Pacira BioSciences
PCRX
|
0.12 | $ 22.91 | 1.04 % | $ 1.06 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 1.15 | -4.96 % | $ 1.43 M | USA |
 |
Solid Biosciences
SLDB
|
-2.03 | $ 6.81 | -6.01 % | $ 596 M | USA |
 |
Aurora Cannabis
ACB
|
0.09 | $ 3.39 | -3.42 % | $ 186 M | Canada |
 |
Jupiter Wellness
JUPW
|
0.16 | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
-2.22 | $ 4.91 | -5.49 % | $ 3.03 B | Canada |
 |
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-0.37 | $ 1.08 | -0.46 % | $ 103 M | Canada |
 |
Evolus
EOLS
|
-0.39 | $ 6.41 | -2.88 % | $ 413 M | USA |
 |
Sundial Growers
SNDL
|
-71 | $ 1.43 | - | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
3.66 | $ 8.09 | -4.03 % | $ 433 M | USA |
 |
cbdMD
YCBD
|
-0.45 | $ 0.74 | -1.61 % | $ 2.98 M | USA |
 |
Veru
VERU
|
-1.68 | $ 3.63 | -14.18 % | $ 53.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-4.7 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
1.32 | $ 23.45 | - | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-1.56 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
8.15 | $ 5.33 | 1.53 % | $ 1.98 B | Canada |
 |
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-1.5 | $ 5.87 | -7.05 % | $ 232 M | USA |
 |
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | USA |
 |
SCYNEXIS
SCYX
|
-0.32 | $ 4.72 | -3.28 % | $ 236 M | USA |
 |
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
2.92 | $ 16.0 | 0.63 % | $ 18.6 B | USA |
 |
Zomedica Corp.
ZOM
|
-0.08 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-0.07 | $ 0.65 | -6.27 % | $ 23.4 M | USA |
 |
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-0.4 | $ 0.83 | 0.97 % | $ 3.56 M |  China |
 |
TherapeuticsMD
TXMD
|
-0.35 | $ 1.95 | -2.5 % | $ 22.6 M | USA |